Both ablation and various lifestyle modifications, like losing weight and exercising more, have roles to play, experts agree.

Just a dozen patients have undergone the new treatment that uses electrical pulses to target problem areas inside the heart.

A copy of the poster can be accessed here. Etripamil for patients with atrial fibrillation with rapid ventricular rate (AFib-RVR) Phase 3 protocol in AFib-RVR finalized ...

Researchers sought to compare the effect of abelacimab vs rivaroxaban on risk for bleeding in patients with atrial fibrillation.

Atrial fibrillation diagnosed before age 70 years was associated with a 21% increased risk for dementia and a 36% increased risk for early-onset dementia in a large population-based study.

The drug is also under study for atrial fibrillation with rapid ventricular rate (AFib-RVR). 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

Milestone Pharmaceuticals, with a focus on addressing unmet patient needs in cardiology, continues to develop etripamil, which has completed Phase 3 trials for PSVT and Phase 2 trials for AFib-RVR.

Milestone plans to initiate a Phase 3 study for the use of etripamil in Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR) in the first half of 2025.

Diltiazem effectively controls heart rate in atrial fibrillation with rapid ventricular rate (AF RVR) but might worsen heart failure due to its adverse inotropic effects in individuals with reduced ...

Introduction: Continuous intravenous (IV) diltiazem is one of the options for urgent management of atrial fibrillation with rapid ventricular response (RVR). This study assesses the clinical outcomes ...

Sept. 12, 2024 – The number of U.S. adults who have a potentially dangerous irregular heartbeat called atrial fibrillation is triple the number that health experts previously thought, according ...

A combined subgroup analysis of the similar trials NOAH—AFNET 6 and ARTESiA has revealed that patients with device-detected atrial fibrillation and concomitant vascular disease are at higher ...